Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
10,000+ US Securities
Unlisted Companies not available on US Stock Exchanges
Professionally managed portfolios, designed by Vested’s research team
Get exposure to 50+ countries via global funds managed by the world’s top fund managers
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey. more
| Time Frame | PTNT | S&P500 |
|---|---|---|
| 1-Week Return | - | 2.71% |
| 1-Month Return | - | 7.5% |
| 3-Month Return | - | 6.55% |
| 6-Month Return | 201.52% | 7.98% |
| 1-Year Return | 505.18% | 26.52% |
| 3-Year Return | -76.93% | 79.06% |
| 5-Year Return | -96.1% | 78.03% |
| 10-Year Return | -96.2% | 257.99% |
| Time Frame | PTNT | S&P500 |
|---|---|---|
| 1-Week Return | 0.00% | 303.20% |
| 1-Month Return | 0.00% | 141.07% |
| 3-Month Return | 0.00% | 29.34% |
| 6-Month Return | 837.45% | 16.85% |
| 1-Year Return | 505.18% | 26.52% |
| 3-Year Return | -38.67% | 21.43% |
| 5-Year Return | -47.73% | 12.23% |
| 10-Year Return | -27.89% | 13.60% |
| Sector | Weight |
|---|---|
|
All Others
|
100.00% |
Palatin Technologies, Inc. (PTNT) share price today is $25.7313.
Yes, Indians can buy shares of Palatin Technologies, Inc. (PTNT) on Vested. To buy PTNT from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of Palatin Technologies, Inc. (PTNT) on Vested. You can start investing in Palatin Technologies, Inc. (PTNT) with a minimum investment of $1.
The 52-week high price of Palatin Technologies, Inc. (PTNT) is $19.5. The 52-week low price of Palatin Technologies, Inc. (PTNT) is $4.25.
The stock symbol (or ticker) of Palatin Technologies, Inc. is PTNT.
Yes, you can setup SIP in Palatin Technologies, Inc. shares. Follow the below steps to create the SIP:
Here is the historical performance of PTNT on the Vested app.
The expense ratio of Palatin Technologies, Inc. (PTNT) is .
Link copied